A congressional committee is proposing an amendment to a spending bill that may intensify the debate over the safety of compounded medicines.
The House Appropriations Committee has introduced language that would alter a key requirement for pharmacists to make and dispense compounded medicines, which are generally customized for specific patient needs. And the language runs counter to a draft guidance that the US Food and Drug Administration released just last week that would govern compounding practices.
Read Full Article »